Considering the high rates of chronic Mtb infection worldwide and the increasing number of multi-drug resistant and extensively drug resistant tuberculosis cases, our study suggests that understanding the role of PYCARD during Mtb infection may lead to new and more effective therapies to treat chronic Mtb infection. The gene discussed is PYCARD; the disease is tuberculosis.